Primary breast feeding. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy17

Breast Cell Line, Tumor Axilla Lymph Nodes Tumor Cells, Cultured MCF-7 Cells Mammary Glands, Human Neoplastic Cells, Circulating Milk, Human Nipples Epithelial Cells Chromosomes, Human, Pair 17 Neoplastic Stem Cells Chromosomes, Human, Pair 11 Bone Marrow Cytosol Chromosomes, Human, Pair 16

Organisms2

Mice, Nude Mice, SCID

Diseases38

Breast Neoplasms Carcinoma, Ductal, Breast Breast Diseases Lymphatic Metastasis Carcinoma, Lobular Breast Neoplasms, Male Neoplasm Metastasis Carcinoma, Intraductal, Noninfiltrating Carcinoma Neoplasm Invasiveness Neoplasm Recurrence, Local Fibrocystic Breast Disease Neoplasms, Hormone-Dependent Neoplasms, Second Primary Fibroadenoma Bone Neoplasms Neoplasms, Multiple Primary Mammary Neoplasms, Experimental Carcinoma in Situ Carcinoma, Ductal Neoplastic Cells, Circulating Bone Marrow Neoplasms Disease Progression Breast Cyst Genetic Predisposition to Disease Ovarian Neoplasms Neoplasm Micrometastasis Triple Negative Breast Neoplasms Inflammatory Breast Neoplasms Recurrence Cell Transformation, Neoplastic Adenocarcinoma Lung Neoplasms Neovascularization, Pathologic Adenocarcinoma, Mucinous Carcinoma, Medullary Neoplasms Neoplasms, Radiation-Induced

Chemicals and Drugs73

Receptors, Estrogen Receptors, Progesterone Receptor, erbB-2 Tamoxifen Tumor Markers, Biological Antineoplastic Agents, Hormonal Neoplasm Proteins Epirubicin DNA, Neoplasm Estrogen Receptor alpha Cyclophosphamide Ki-67 Antigen Antineoplastic Agents RNA, Messenger Mucin-1 Estrogens Aromatase Inhibitors Estrogen Antagonists BRCA2 Protein RNA, Neoplasm Antigens, CD24 BRCA1 Protein Cathepsin D Nitriles Triazoles Taxoids Urokinase-Type Plasminogen Activator Fluorouracil Antibodies, Monoclonal Selective Estrogen Receptor Modulators Antigens, Neoplasm Tumor Suppressor Protein p53 Tumor Suppressor Proteins Antibodies, Monoclonal, Humanized Estradiol Mammaglobin A Receptors, Estradiol Receptor, Epidermal Growth Factor Fibroblast Growth Factor 3 Plasminogen Activator Inhibitor 1 Keratins Aminoglutethimide RNA, Small Interfering Doxorubicin Anthracyclines Estrogen Receptor Modulators Plasminogen Activator Inhibitor 2 Retinal Dehydrogenase Antigens, Tumor-Associated, Carbohydrate Methotrexate Cyclin D1 Transcription Factors Nuclear Receptor Coactivator 3 Antineoplastic Agents, Phytogenic Proto-Oncogene Proteins Cadherins Radiopharmaceuticals Estrogen Receptor beta Receptor, erbB-3 Clodronic Acid Antigens, CD44 DNA-Binding Proteins Genetic Markers Nuclear Proteins Antibiotics, Antineoplastic Fluorodeoxyglucose F18 Oncogene Proteins Goserelin Carcinoembryonic Antigen Uteroglobin DNA Primers Tissue Inhibitor of Metalloproteinase-1 Proto-Oncogene Proteins c-bcl-2

Analytical, Diagnostic and Therapeutic Techniques and Equipment76

Prognosis Mastectomy Mammography Immunohistochemistry Chemotherapy, Adjuvant Neoplasm Staging Disease-Free Survival Breast Implants Neoadjuvant Therapy Ultrasonography, Mammary Mastectomy, Segmental Survival Analysis Antineoplastic Combined Chemotherapy Protocols Follow-Up Studies Breast Self-Examination Multivariate Analysis Biopsy, Needle Mastectomy, Radical Gene Expression Profiling Risk Factors Survival Rate Predictive Value of Tests Treatment Outcome Reverse Transcriptase Polymerase Chain Reaction Case-Control Studies Retrospective Studies In Situ Hybridization, Fluorescence Mammaplasty Mammary Neoplasms, Experimental Prospective Studies Sensitivity and Specificity Proportional Hazards Models Immunoenzyme Techniques Oligonucleotide Array Sequence Analysis Tissue Array Analysis Cohort Studies Sentinel Lymph Node Biopsy Mastectomy, Modified Radical Lymph Node Excision Biopsy, Large-Core Needle Risk Reproducibility of Results Incidence Radiotherapy, Adjuvant Biopsy SEER Program Risk Assessment Kaplan-Meier Estimate Polymerase Chain Reaction Combined Modality Therapy Neoplasm Grading Transplantation, Heterologous Breast Implantation Blotting, Western Odds Ratio Neoplasm Transplantation Tumor Burden Logistic Models Radiotherapy Paraffin Embedding Mass Screening Drug Administration Schedule Analysis of Variance DNA Mutational Analysis Enzyme-Linked Immunosorbent Assay Registries Transfection Regression Analysis Xenograft Model Antitumor Assays Positron-Emission Tomography Randomized Controlled Trials as Topic False Negative Reactions Clinical Trials as Topic Preoperative Care Probability Drug Screening Assays, Antitumor

Psychiatry and Psychology2

Breast Feeding Breast Self-Examination

Phenomena and Processes54

Breast Feeding Gene Expression Regulation, Neoplastic Genes, erbB-2 Menopause Gene Amplification Postmenopause Genes, BRCA1 Premenopause Time Factors Drug Resistance, Neoplasm Cell Proliferation Sensitivity and Specificity Genes, BRCA2 DNA Methylation Risk Loss of Heterozygosity Genes, Tumor Suppressor Mutation Genetic Predisposition to Disease Genes, p53 Gene Expression Signal Transduction Chromosomes, Human, Pair 17 Ploidies Promoter Regions, Genetic Down-Regulation Up-Regulation Odds Ratio Cell Growth Processes Apoptosis Cell Division Phenotype Cell Movement Gene Silencing Germ-Line Mutation Base Sequence Epithelial-Mesenchymal Transition Genes, Neoplasm Alleles Transfection CpG Islands Gene Dosage Chromosomes, Human, Pair 11 Dose-Response Relationship, Drug Genetic Markers Heterozygote Phosphorylation Genotype Polymorphism, Single Nucleotide Probability Polymorphism, Single-Stranded Conformational Chromosomes, Human, Pair 16 RNA Interference Cell Cycle

Disciplines and Occupations1

Immunohistochemistry

Technology, Industry, Agriculture1

Information Science6

Survival Rate Incidence SEER Program Base Sequence Registries Molecular Sequence Data

Health Care31

Disease-Free Survival Survival Analysis Follow-Up Studies Multivariate Analysis Risk Factors Survival Rate Predictive Value of Tests Treatment Outcome Case-Control Studies Retrospective Studies Age Factors Prospective Studies Sensitivity and Specificity Proportional Hazards Models Cohort Studies Risk Reproducibility of Results Incidence SEER Program Risk Assessment Kaplan-Meier Estimate Odds Ratio Logistic Models Mass Screening Analysis of Variance Registries Regression Analysis Randomized Controlled Trials as Topic Clinical Trials as Topic Preoperative Care Probability

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Breast Breast Neoplasms Carcinoma, Ductal, Breast Receptors, Estrogen Breast Diseases Receptors, Progesterone Receptor, erbB-2 Lymphatic Metastasis Prognosis Tamoxifen Carcinoma, Lobular Mastectomy Tumor Markers, Biological Breast Neoplasms, Male Breast Feeding Cell Line, Tumor Gene Expression Regulation, Neoplastic Neoplasm Metastasis Mammography Immunohistochemistry Axilla Antineoplastic Agents, Hormonal Chemotherapy, Adjuvant Carcinoma, Intraductal, Noninfiltrating Neoplasm Staging Disease-Free Survival Carcinoma Neoplasm Invasiveness Neoplasm Proteins Breast Implants Neoplasm Recurrence, Local Neoadjuvant Therapy Ultrasonography, Mammary Genes, erbB-2 Mastectomy, Segmental Survival Analysis Menopause Lymph Nodes Fibrocystic Breast Disease Neoplasms, Hormone-Dependent Tumor Cells, Cultured Epirubicin Neoplasms, Second Primary Gene Amplification DNA, Neoplasm Estrogen Receptor alpha Cyclophosphamide Ki-67 Antigen Antineoplastic Combined Chemotherapy Protocols Postmenopause Genes, BRCA1 Follow-Up Studies Breast Self-Examination Multivariate Analysis Biopsy, Needle Mastectomy, Radical Antineoplastic Agents Gene Expression Profiling Risk Factors Survival Rate Fibroadenoma Predictive Value of Tests RNA, Messenger Treatment Outcome Reverse Transcriptase Polymerase Chain Reaction Case-Control Studies Premenopause Retrospective Studies Mucin-1 Estrogens MCF-7 Cells In Situ Hybridization, Fluorescence Aromatase Inhibitors Mammary Glands, Human Estrogen Antagonists Bone Neoplasms Time Factors Mammaplasty Drug Resistance, Neoplasm Neoplasms, Multiple Primary Mammary Neoplasms, Experimental Carcinoma in Situ Carcinoma, Ductal Neoplastic Cells, Circulating BRCA2 Protein Cell Proliferation Age Factors Prospective Studies RNA, Neoplasm Sensitivity and Specificity Proportional Hazards Models Antigens, CD24 Bone Marrow Neoplasms BRCA1 Protein Immunoenzyme Techniques Oligonucleotide Array Sequence Analysis Tissue Array Analysis Cohort Studies Sentinel Lymph Node Biopsy Cathepsin D

No FAQ available that match "primary breast feeding"